Cargando…
Toxicological Characterization of GHB as a Performance-Enhancing Drug
Performance-enhancing drugs (PEDs) are represented by several compounds used to ameliorate the image, the appearance, or an athletic or non-athletic performance. Gamma-hydroxybutyrate (GHB) is an endogenous molecule first used as anesthetic and then marketed as a nutritional supplement with a wide d...
Autores principales: | Giorgetti, Arianna, Busardò, Francesco Paolo, Giorgetti, Raffaele |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9058118/ https://www.ncbi.nlm.nih.gov/pubmed/35509886 http://dx.doi.org/10.3389/fpsyt.2022.846983 |
Ejemplares similares
-
Post-Mortem Toxicology: A Systematic Review of Death Cases Involving Synthetic Cannabinoid Receptor Agonists
por: Giorgetti, Arianna, et al.
Publicado: (2020) -
Psychomotor performances relevant for driving under the combined effect of ethanol and synthetic cannabinoids: A systematic review
por: Giorgetti, Arianna, et al.
Publicado: (2023) -
Ultra-High-Performance Liquid Chromatography Tandem Mass Spectrometry Assay for Determination of Endogenous GHB and GHB-Glucuronide in Nails
por: Busardò, Francesco Paolo, et al.
Publicado: (2018) -
Synthetic Benzimidazole Opioids: The Emerging Health Challenge for European Drug Users
por: Di Trana, Annagiulia, et al.
Publicado: (2022) -
Editorial: Toxicological profiles and pharmacological properties of synthetic cannabinoids: From chemical and analytical issues to fatal and non-fatal intoxications
por: Giorgetti, Arianna, et al.
Publicado: (2023)